Zhejiang Medicines & Health Products Import & Export Co., Ltd.
Zhejiang Medicines & Health Products Import & Export Co., Ltd., commonly referred to as Zhejiang Pharma, is a prominent player in the pharmaceutical and health products industry, headquartered in China. Established in 2001, the company has steadily expanded its operations across various regions, focusing on the import and export of high-quality medicines and health products. Zhejiang Pharma is renowned for its diverse portfolio, which includes prescription medications, over-the-counter drugs, and health supplements. The company distinguishes itself through rigorous quality control and adherence to international standards, ensuring the safety and efficacy of its products. With a strong market presence, Zhejiang Pharma has achieved significant milestones, positioning itself as a trusted partner in the global healthcare supply chain.
DitchCarbon Score
How does Zhejiang Medicines & Health Products Import & Export Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Food Product Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Zhejiang Medicines & Health Products Import & Export Co., Ltd.'s score of 24 is higher than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Zhejiang Medicines & Health Products Import & Export Co., Ltd.'s reported carbon emissions
In 2024, Zhejiang Medicines & Health Products Import & Export Co., Ltd. reported significant carbon emissions, totalling approximately 29,924,180 kg CO2e for Scope 1, 3,169,805 kg CO2e for Scope 2, and 11,981,332 kg CO2e for Scope 3. The combined emissions for Scope 1 and 2 reached about 61,622,230 kg CO2e. This represents a notable increase from 2023, where emissions were approximately 598,881,000 kg CO2e for Scope 1, 1,118,281,000 kg CO2e for Scope 2, and 9,767,259,000 kg CO2e for Scope 3, with a total of about 1,717,162,000 kg CO2e for Scope 1 and 2 combined. The company has set ambitious near-term carbon neutrality goals, focusing on reducing emissions in both Scope 1 and Scope 2 by 2025. This initiative includes the construction of "zero carbon" factories, aimed at ensuring a structured approach to achieving their carbon neutrality objectives. Zhejiang Medicines & Health Products Import & Export Co., Ltd. has disclosed emissions data across all three scopes, demonstrating transparency in their climate commitments. The company does not currently inherit emissions data from any parent organisation, indicating that their reported figures are independently sourced.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | 2024 | |
|---|---|---|
| Scope 1 | 598,881,000 | 0,000,000,000 |
| Scope 2 | 1,118,281,000 | 0,000,000,000 |
| Scope 3 | 9,767,259,000 | 00,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Zhejiang Medicines & Health Products Import & Export Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
